Authors: Johnson, KP Brooks, BR Ford, CC Goodman, A Guarnaccia, J Lisak, RP Myers, LW Panitch, HS Pruitt, A Rose, JW Kachuck, N Wolinsky, JS

Citation: Kp. Johnson et al., Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years, MULT SCLER, 6(4), 2000, pp. 255-266

Authors: Rudick, RA Goodman, A Herndon, RM Panitch, HS

Citation: Ra. Rudick et al., Selecting relapsing remitting multiple sclerosis patients for treatment: the case for early treatment, J NEUROIMM, 98(1), 1999, pp. 22-28

Authors: Johnson, KP Panitch, HS

Citation: Kp. Johnson et Hs. Panitch, Interferon beta treatment for multiple sclerosis, LANCET, 353(9151), 1999, pp. 494-494

Authors: Ford, CC Brooks, BR Johnson, KP Lisak, RP Myers, LW Panitch, HS Rose, JW Schiffer, RB Vollmer, T Weiner, LP Wolinsky, JS

Citation: Cc. Ford et al., Sustained efficacy of glatiramer acetate for injection in a 5+ year trial of relapsing remitting MS, MULT SCLER, 4(6), 1998, pp. 521-521